Vovantis Laboratories

What Vovantis Laboratories does

Vovantis Laboratories is a privately held pharmaceutical contract manufacturer incorporated in 2008, specializing exclusively in novel effervescent drug delivery systems. The company operates from an international-standard manufacturing facility in Ranoli, Vadodara, Gujarat, India, compliant with USFDA, WHO GMP, ISO 13485:2003, and ISO 9001:2000 standards. Vovantis offers end-to-end B2B contract manufacturing services including formulation development, pilot batch analysis, commercial batch production, and customized labeling and packaging across multiple formats (strip foils, cartons, tubes, sachets).

The company's product portfolio spans OTC products (denture cleansers, cold/flu remedies), prescription pharmaceuticals (paracetamol, sildenafil, tramadol, NSAIDs, mucolytics), value-added nutraceuticals (vitamins, minerals, electrolytes, multivitamins, energy drink formulations), and herbal/ayurvedic effervescent formulations. Vovantis' R&D team brings over 25 years of specialized effervescent formulation experience, enabling development across medical, hygiene, personal care, household, and veterinary categories. The technology differentiator is proprietary know-how in effervescent formulation chemistry rather than disclosed patents.

The business model is private label contract manufacturing for pharmaceutical and supplement brand owners globally. Revenue is generated through one-time manufacturing contracts with quote-based pricing determined per customer specifications and order volumes. Products are sold worldwide through direct enterprise sales outreach, with no disclosed marketing channels beyond the company website and direct email contact. No customer logos, revenue figures, or funding history are publicly disclosed, and the company appears to be founder-owned with no known external investors or acquisition activity.

Name

Vovantis Laboratories

Legal name

Vovantis Laboratories Pvt. Ltd.

Website

https://vovantis.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Vovantis Laboratories is a privately held Indian pharmaceutical contract manufacturer specializing in novel effervescent drug delivery systems, serving private label pharmaceutical and supplement brand owners globally with formulation development, manufacturing, and customized packaging services.

Ownership category

akta.pro rank

Headquarters

HQ city

Vadodara

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Manufacturing effervescent products for private label customers worldwide, including product development, pilot batch analysis, commercial batches, and customized labeling and packaging services for strip foils, cartons, tubes, and sachets.
2. Product Sales (Private Label): Sale of manufactured effervescent pharmaceutical, OTC, and dietary supplement products under customer private labels for global distribution.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Vovantis Laboratories is a pharmaceutical contract manufacturer specializing in novel effervescent drug delivery systems. The company develops and produces effervescent tablets and granules for pharmaceutical, OTC, dietary supplement, and herbal/ayurvedic applications, offering end-to-end services from R&D and formulation through pilot batches, commercial manufacturing, and customized packaging (strips, tubes, sachets, cartons) for private label customers worldwide.

Product overview

Vovantis Laboratories is a pharmaceutical manufacturer specializing in novel effervescent drug delivery systems, incorporated in 2008 and based in India. The company offers a comprehensive portfolio of effervescent products organized into four main categories: OTC Products (including denture cleansers), Pharma Products (prescription medications like paracetamol, sildenafil, tramadol, NSAIDs, and cold/flu treatments), Value Added Products (vitamins, minerals, electrolytes, energy drinks, and dietary supplements), and Herbal/Ayurvedic Products (curcumin and herbal combinations). Vovantis provides complete contract manufacturing services including product development, pilot batch analysis, commercial manufacturing, and customized labeling and packaging for various formats including strip foils, cartons, tubes, and sachets. The company operates under WHO GMP, ISO 13485:2003, and ISO 9001:2000 certifications and serves customers worldwide through private label arrangements.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services End-to-end B2B contract manufacturing of effervescent products, including product development/formulation, pilot batch analysis, commercial batch manufacturing, and customized labeling and packaging for strip foils, cartons, tubes, and sachets. Targeted at pharmaceutical, OTC, nutraceutical, and herbal/ayurvedic brand owners seeking private label manufacturing partners.
• Effervescent Pharmaceutical Tablets Prescription-grade effervescent tablets including paracetamol (multiple dosages), sildenafil citrate, tramadol hydrochloride, diclofenac, citicoline, N-acetyl cysteine, potassium citrate, sodium acid phosphate, and ORS (WHO formula). Available in strip and tube packaging for export markets.
• Effervescent OTC Products
• Effervescent Vitamin and Mineral Supplements
• Effervescent Herbal and Ayurvedic Products
• Effervescent Salt Granules

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Bayer Consumer Health: Global consumer healthcare major with leading effervescent brands (e.g., Berocca, Aspirin Plus C). Comparable as a buyer of effervescent contract manufacturing services and as a competitor in the effervescent product category, though vertically integrated rather than contract-focused.
• Sun Pharmaceutical Industries: India's largest pharmaceutical company with global manufacturing operations and USFDA-approved facilities. Comparable regulatory credentials and export-oriented B2B model, though at significantly greater scale and broader therapeutic scope.
• Dr. Reddy's Laboratories: Major Indian pharmaceutical manufacturer with USFDA-approved facilities serving global generics and CMO markets. Comparable as a low-cost Indian pharma manufacturer competing in regulated export markets, though with much broader therapeutic and dosage-form coverage.
• Catalent: Global pharmaceutical CDMO offering oral, injectable, and biologics contract manufacturing services. Comparable as a B2B contract manufacturer serving pharma brands worldwide, though operating at vastly different scale and across multiple dosage forms.
• Recipharm: European pharmaceutical CDMO with multiple manufacturing sites and broad dosage-form capabilities. Comparable as a contract manufacturer serving global pharma customers with GMP-compliant facilities, though much larger and more diversified.
• Cadila Healthcare (Zydus): Major Indian pharmaceutical company with strong API, generics, and consumer wellness operations including effervescent products. Comparable as Indian pharma manufacturer with global regulatory approvals and B2B/private-label business.
• Cipla: Leading Indian pharmaceutical company with global manufacturing footprint and USFDA-compliant facilities. Comparable in regulatory certifications, B2B pharma export model, and contract manufacturing capabilities, though at substantially larger scale.
• Aurobindo Pharma: Large Indian generic and contract manufacturer with extensive oral solid dose capabilities across global regulated markets. Comparable in regulatory compliance footprint (USFDA-approved) and B2B export orientation, though vastly larger and broader in scope.

Direct peers

• Losan Pharma: German CDMO with strong effervescent and orally disintegrating tablet capabilities, offering formulation development through commercial manufacturing. Directly comparable business model and dosage-form focus.
• Hermes Pharma: German pharmaceutical CDMO specializing in user-friendly dosage forms including effervescent tablets, instant drinks, and chewables. Most direct comparable: similar niche focus on novel oral dosage formats serving global pharma and supplement brands via contract manufacturing.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vovantis Laboratories